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S_nary The co-injection of extracellular matrix components, such as Matrigel, with human tumour cells
into nude mice has been reported to facilitate tumour formation and growth, but it is unknown whether such
components exert siilar effects on tumour progression and metastasis. Metastatic behaviour is known to be
enhanced when tumour cells are implanted orthotopically, and it is inferred that full and efficient expression of
this phenotype may involve some interactions with local connective tissue matrix. It was therefore decided to
investigate whether manipulation of the mesenchymal environment by co-injection of extracelular matrix
components, in the form of Matrigel, with human breast cancer cells into orthotopic or ectopic sites could
augment their metastatic performance, as well as their growth at the site of inoculation. Standard aliquots of
10' cels of the polyclonal hunan breast carcinoma cell line MDA-MB-435, and of four clonal cell lines, two
metastatic and two non-metastatic derived from it, were injected with and without Matrigel, orthotopicaDly or
subcutaneously into nude mice. The latent period of tumour formation at the inoculation site as well as final
tumour size and metastatic performance at autopsy, 140 days after inoculation, were then assessed. The
prevaknce ofmetastasis of the parent, polyclonal, cell line and of its metastatic clones was increased if the cell
inoculum was mixed with Matrigel. Non-metastatic clones were not induced to become metastatic by this
treatment, but local tumour growth at the site of inoculation was enhanced in all experimental groups
receiving Matrigel. Orthotopic inoculation acted synergistically with Matrigel to maximise both tumour
growth and metastatic behaviour. The composition of the local extracellular matrix at the site of tumour
growth influenced expression of the metastatic phenotype by cells which are constitutionally capable of this
behaviour, but did not induce it in ones which are not. Previous reports that local tumour growth is facilitated
by enrichment of the mesenchymal matrix are confirmed. The mechanisms by which such effects are exerted
are worthy of study, to ascertain whether they might be subject to clinical manipulation designed to retard
tumour growth and dissemination.
The discovery that mutant athymic nude mice do not reject
heterotransplants of human tumour tissue (Rygaard & Povl-
sen, 1969) provided new opportunities for experimental
studies on human tumours, including the analysis of their
metastatic properties. However, several subsequent reports
noted that the prevalence of tumour formation by xeno-
grafted fresh primary human tumour fragments in nude mice
is low, approximately 30% (Sharkey & Fogh, 1984), al-
though the 'take rate' with passaged tumour cell lines (Fogh
et al., 1977) and with tissues from metastases (Sharkey &
Fogh, 1984) is about double this. Also, many tumour
implants and cell lines, including those derived from highly
malignant human cancers, fail to form metastases in adult
nude mice, even if they do grow at the site of implantation
(Sharkey & Fogh, 1978; Fidler, 1986) and the animals are
expensive, delicate and highly susceptible to infection. These
difficulties have impeded and delayed extensive use of nude
mouse xenografts in research on mechanisms of human
tumour metastasis. Even so, the goal of being able to study
this event in a living host has motivated investigators to
persist in efforts to induce human tumour cells to re-enact
the metastatic process in experimental animals. Variables that
have been found to affect whether metastasis occurs include
the health and housing conditions of the mice (Sharkey &
Fogh, 1978; Neulat-Duga et al., 1984; Fidler, 1986), the level
of natural killer (NK)-cell activity, age of the host (Fidler,
1986) and the route of tumour cell inoculation (Kozlowski et
al., 1984; Giavazzi et al., 1986), in addition to the intrinsic
properties of the tumours under investigation.
Of the several human tumour types now becoming
available for the study of metastasis in the nude mouse, one
of the most interesting for future study is the MDA-MB-435
cell line isolated from a pleural effusion in a patient with
breast cancer (Caillou et al., 1978). Price et al. (1990)
reported that orthotopic implantation of cells of this line into
the mammary fat pad (mfp) of nude mice could enhance its
tumorigenicity in this host, and these tumours were found to
be more metastatic than those formed after subcutaneous
inoculation. These findings confirm and extend similar obser-
vations, reported in recent years (Bresalier et al., 1987;
Morikawa et al., 1988), with colon carcinoma cell lines.
Tumours formed by these cell lines following intramural
injection in the colon are more metastatic than those result-
ing from subcutaneous inoculation. An orthotopic microen-
vironment evidently encourages tumour cells to express the
malignant phenotype (See also Fidler, 1990). This raises the
question of how such an effect might be mediated and what
it might signify.
In vivo, carcinoma ceUs are surrounded by cellular connec-
tive tissue composed of fibroblasts, endothelium and other
cells in a dense network of extracellular matrix proteins
which provides them all with a three-dimensional structural
framework and influences their behaviour. The interdepen-
dency of these elements is illustrated by some recent experi-
mental observations. For example, Fabra et al. (1992)
demonstrated that highly metastatic KM12SM colon car-
cinoma cells co-cultivated with fibroblasts from the colon are
able to demonstrate an invasive phenotype and produce type
IV collagenase, whereas the same line cultivated with skin
fibroblasts can not. These carcinoma cells are metastatic
from tumours formed after intramural inoculation in the
colon but not after subcutaneous inoculation.
Recent investigations have also indicated that tumour
growth and behaviour is influenced by non-cellular elements
of the adjacent connective tissue matrix. In these studies it
was found that a reconstituted basement membrane deriva-
tive termed Matrigel, composed mainly of laminin, collagen
type IV, heparan sulphate proteoglycan and entactin, greatly
enhances the tumorigenicity of various malignant cells, in-
cluding small-cell lung carcinomas, B16-FIO melanoma,
human submandibular A253 carcinoma, prostate carcinoma
cell lines and primary colon carcinoma cells (Fridman et al.,
1990, 1991; Pretlow et al., 1991) Tumour cells premixed with
Matrigel and then injected into athymic mice consistently
produced tumours which grew faster and became much
larger than tumours induced by the same cells injected with-
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out Matrigel. Fridman et al. (1992) also showed that non-
transformed and non-tumorigenic NIH-3T3 cells formed
locally invasive and highly vascularised tumours when co-
injected with Matrigel into athymic mice. The cells isolated
from the Matrigel-induced tumours exhibited cellular charac-
teristics similar to that observed in NIH-3T3 cells after
malignant transformation and were capable of forming pul-
monary tumour colonies when injected i.v. These studies
suggested that interaction of premalignant NIH-3T3 cells
with extracellular matrix components can contribute to the
process of tumour progression. In the current experiments we
studied whether Matrigel would affect the growth of tumours
formed in nude mice by human breast carcinoma cell lines
with different metastatic potentials. We also investigated the
effect of this material on the incidence of metastasis from
tumours formed by these lines after injection subcutaneously
or into the mfp. The results showed that Matrigel could
enhance the growth of tumours, in both sites, regardless of
the degree of malignancy of the cell line. Matrigel could also
increase the incidence of spontaneous metastasis from
tumours formed by cell clones of the MDA-MB435 line
which have some intrinsic metastatic capability, but did not
induce any metastatic behaviour in clones which had no such
inherent tendency.
Materias and methods
Animals
Athymic nude mice (MFlNu) were obtained from the breed-
ing facility at the John Radcliffe Hospital, Oxford, UK. Mice
were injected with tumour cells when 6-8 weeks old and
were kept in filter-top boxes in an isolated colony. Care of
animals in this work was conducted according to United
Kingdom Home Office and Oxford University regulations.
Cell culture The polyclonal human breast carcinoma cell
line MDA-MB-435 and the clonal cell lines Cl, C2, C3 and
C4 we derived from it by a limiting dilution technique were
maintained in Dulbecco's modified Eagle medium (DMEM)
supplemented with 5% newborn calf serum, sodium
pyruvate, L-glutamine (2mM), non-essential amino acid and
2 x vitamin solution (Gibco). The cultures were incubated at
37C in a humidified atmosphere of 5% carbon dioxide-95%
air. Tumour cells were harvested by washing the monolayer
with phosphate-buffered saline (PBS) followed by brief
incubation in 0.25% trypsin-0.02% EDTA at 3rC. The
cells were then washed by centrifugation and resuspended in
DMEM in preparation for inoculation. Clones Cl to C4
were chosen for use in this study on the basis of earlier
assays of their metastatic capabilities (see below) when
injected suspended in culture medium alone.
Matrigel
Matrigel was extracted from fresh pieces of the mouse Eng-
lebreth-Hohm-Swarm (EHS) tumour as described previ-
ously (Kleiman et al., 1986, 1990). Briefly, 100 g of the
tumour tissue was washed in chilled 3.4 M sodium chloride
and 0.05 M Tris-HCl, pH 7.4, containing 5 mgml-' protease
inhibitor, and homogenised in 150 ml of 2 M urea with
0.05 M Tris-HCI, pH 7.4. The sample was left stirring over-
night at 4°C and was then centrifuged at 10,000g for 30min.
The supernatant was collected and the solid residue was
washed once with the same volume of buffer. Then the
supernatant and wash were combined, dialysed against
0.15 M sodium chloride in 0.05 M Tris-HCl, pH 7.4 (TBS),
for 6 h, and subsequently against PBS and DMEM and
finally centrifuged at 15,000 r.p.m. for 20 min to remove any
residual insoluble material. The supernatant fraction was
stored at -20°C in small aliquots until used in the
experiments.
Tunour cell inoculation
The tumour cells were harvested and resuspended in cold
DMEM, mixed with an equal volume of cold (4C) liquid
Matrigel and immediately injected s.c. or in the mfp. During
inoculation the stock cell suspension in Matrigel was kept
chilled in an ice bucket to ensure that it did not begin to gel,
as the extract readily does at 37C. Mice in control groups
were given subcutaneous and mfp injections of 106 tumour
cells in 0.1 ml of DMEM with no Matrigel. For inoculation
into the mfp the mice were anaesthetised with Metofane and
a 5 mm incision was made in the skin over the flank. The
mfp was exposed and 0.1 ml of fluid containing 106 cells was
injected into the tissue of the gland through a 27 gauge
needle. By exposing the fat pad, we were able to ensure that
the cells were injected into the tissue and not into the s.c.
space. Tumour cells were injected s.c. remote from the mfp,
in separate groups of animals.
Tumorigenicity andmetastasLs in vivo
The tumorigenicity and spontaneous metastatic capability of
the cells were observed following subcutaneous and mfp
injections of 1 x 106 cells in 0.1 ml of DMEM into the lower
right hind flank of nude mice. The animals were monitored
every 2-3 days for over 4 months for the presence of a
grossly visible and palpable mass at the injction site. Local
primary tumour growth was evaluated by measurement of
mean latent period and of eventual size at 140 days after
injection. Autopsy was performed at 140 days, or sooner if
the tumours were large or the host was ill or distressed.
Metastasis formation was studied by macroscopic examina-
tion of all major organs of inoculated mice for secondary
tumours and by histological examination of major organs
and lymph nodes. The prevalence of metastasis in each batch
of inoculated animals and the numbers of surface deposits
seen in the lungs and other organs of each animal were
recorded. Tissues were fixed in 10% neutral formalin and
paraffin embedded for histological confirmation of macro-
scopic observations.
Resuts
Effect ofMatrigel on metastasis
Spontaneous metastasis from tumours formed at the site of
inoculation by metastatic cell lines was reproducibly in-
creased by Matrigel and more so by orthotopic inoculation
(Table I). The details are as follows:
Polyclonal parent MDA-MB-435 line The prevalence of
metastasis from tumours formed by the polyclonal MDA-
MB-435 cell line was greater when the original inoculum was
premixed with Matrigel before injection s.c. or in the mfp
(Table I).
Clonal cell lines Via the s.c. route, cell lines Cl and C2
without Matrigel produced visible lung metastases in 21°%
(Cl) and 37% (C2) of injected mice, respectively, and extra-
pulmonary (hepatic) metastases in only one mouse (C2).
When premixed with Matrigel these cell lines exhibited in-
creased metastasis to the lung and to extrapulmonary sites.
The prevalence of pulmonary metastasis in these groups of
animals was 47% (Cl) and 56% (C2) respectively. C2 cells
also produced metastases in the liver, spleen and kidney (3 of
16 mice, i.e. 19%), but Cl did not. Via the mfp route,
without Matrigel, clone Cl produced lung metastases in 44%
and C2 in 53% of mice. Only clone C2 produced a solitary
extrapulmonary metastasis, and this was in the liver. Meta-
static properties were increased when cells were premixed
with Matrigel and inoculated in this site. Many mice de-
veloped easily visible lung colonies by 4 months. Cl pro-
duced pulmonary metastases in 60% of mice and C2 in 79%.
Cl did not produce any extrapulmonary deposits, but with230 L. BAO et al.
Table I Effect of Matngel on metastasis of MDA-MBA-435 cell lines
Prevalence of
publonary metastasis' (%)
Cell line Injection route No Matrigel With Matrigel Number ofcolonies' PC
MDA-MB-435 poly s.c. 6/29 (21) 12/23 (52) 1 (0-3) 2 (0-4) <005 mfp 7/17 (41) 12/18 (67) 1 (0-5) 3 (0-10)
MDA-MB435 Cl s.c. 5 23 (21) 7/15 (47) 2 (0-5) 2 (0-8)
mfp 7/16 (44) 12/20 (60) 2 (0-5) 3 (0-9) <005
MDA-MB-435 C2 s.c. 9124 (37) 9/16 (56) 2 (0-4) 2 (0-14) <005 mfp 8115 (53) 15/19 (79) 2 (0-6) 4 (0-19)
MDA-MB-435 C3 s.c. 0/19 0/13 0 0
mfp 0/15 0/14 0 0 NS
MDA-MB-435 C4 s.c. 0/12 0/17 0 0
mfp 0/13 1/17 (6) 0 0 (0-2) NS
'Mice with metastases. Mice with tumours. 'Median and range. 'Significance tested with 2 x 2 x2 test.
C2 metastases were seen in the liver, spleen or kidneys in
26% of mice.
Cell line C3 did not form any metastases via either the s.c.
or the mfp route. Though cells premixed with Matrigel pro-
duced earlier and larger tumours in both s.c. and mfp sites,
no lung or other deposits could be found in any mice. None
was found in animals injected by either route without Mat-
rigel. Similarly, clone C4 produced only two pulmonary de-
posits in a single mouse. This was injected in the mfp with
cells mixed with Matrigel. None of the remaining animal
injected with these cells, with or without this matrix material
in either site, had metastases in any organ.
Effect ofMatrigel on the growth oftwnoursformedby
polyclonal MDA-MB-435 cells
Subcutaneous tumour growth When aliquots of I x 106
polyclonal MDA-MB435 cells premixed with liquid Matrigel
or suspended in culture medium alone were injected into
nude mice by either s.c. or mfp routes, all animals developed
tumours. However, the growth of s.c. tumours formed by
cells in culture medium alone, without Matrigel, was slowest.
No visible tumours were apparent within a period of20 days.
The mean time required for a tumour to reach a size of I cm
(latency period) was 135 days (± 10 days). The most slowly
growing of these tumours reached a size of 10.4mm when
the animal was killed 140 days after inoculation. Tumours
appeared sooner and reached larger final dimensions in
animals receiving cells premixed with Matrigel subcutane-
ously. The latency period was 120 days (± 8 days).
Mammary tumour growth The cells in culture medium
alone, injected into mfp, produced tumours with similar
growth to s.c. tumours formed by cells mixed with Matrigel.
The fastest growing tumours were found in the mice injected
in the mfp with cells premixed with Matrigel (Figure 1).
These were visible 20 days after inoculation. The latency
period to I cm diameter was 80 days (± 5 days). The largest
tumour found in this group had reached a diameter of
29.9 mm at 140 days after inoculation.
Effect ofMatrigel on the growth oftumoursformedby
MDA-MB-435 cell clones with different metastatic potentials
Four clonal cell lines derived from the parent MDA-MB-435
line were selected to study the effect of Matrigel on the
growth and behaviour of tumour cells with different meta-
static potentials. Clones Cl and C2 were known from our
previous assays to be metastatic via i.v. and s.c. routes.
Conversely, clone C3 was completely non-metastatic by
either i.v. or s.c. injection, and C4 produced only two lung
metastases in I out of28 animals (3%) (Table I). The growth
of tumours formed by cells premixed with Matrigel was
faster than corresponding tumours formed by cells not mixed
with Matrigel, in both s.c. and mfp sites (Figure 2). The
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degree ofenhancement judged by final tumour size seemed to
be the same whether the tumours were formed by metastatic
cell clones or by non-metastatic ones (data not shown). There
was no evidence of correlation of growth enhancement with
metastatic capability in these four cell clones tested.
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Previous studies by other groups have established that when
the reconstituted basement membrane material Matrigel is
co-injected s.c. with vanrous human and murine tumour cell
lines or with freshly dissociated primary human tumour cells
the prevalence and the growth rates of local primary tumours
are increased (Fridman et al., 1990, 1991; Pretlow et al.,
1991). In the present study we found that Matrigel facilitated
not only the growth but also the metastasis of tumours
formed by the human breast carcinoma line MDA-MB-435
in nude mice and by some of the clones derived from it.
From this body ofdata it is evident that ajudicious choice of
tumour cell line, site of inoculation and facilitatory,
mesenchymally derived, tissue constituents can now enable
an investigator reliably to observe and analyse the metastatic
spread of human tumour cells in the body of the nude
mouse.
At present, there is insufficient information available to
define the active components in Matrigel which affect tumour
growth and metastasis formation. Laminin, the major consti-
tuent of Matrigel, has been shown to accelerate the attach-
ment, activation and growth of tumour cells (Fridman et al.,
1990, 1991), and to increase tumour metastases when injected
intravenously with B16F1O melanoma cells (Barsky et al.,
1984; Terranova et al., 1984). However, I in in alone does
not promote tumour growth as effectively as Matrigel in the
s.c. site (Fridman et al., 1990). Collagen IV, entactin and
heparan sulphate proteoglycan are also biologically active
and may contribute to the growth, adhesion, spreading and
motility of tumour cells (Aumailley & Timpl, 1986; Clement
et al., 1989; Chakravarti et al., 1990). Further experiments
involving sequential addition of such components to laminin
in the medium in which the inoculated cells are suspended
could help to analyse which of these constituents of Matrigel
mediates its faclitatory effects on metastasis. The physical
consistency of Matrigel is also more viscous than that of
culture medium, and this may make some contribution to its
observed effects. It is possible that this inhibits scattering of
tumour cells after inoculation and thereby promotes relevant
interactions between themselves and with surrounding cells
(see below).
Recent studies with different human and murine tumour
cell lines have shown that the site of inoculation can
influence whether distant metastases are formed (Ahlering et
al., 1987; Bresalier et al., 1987; Morikawa et al., 1988; Price
et al., 1990), although it is not clear how the local tissue
environment exerts this effect. The present work confirms
that the mfp is a more favourable site than the subcutis for
the growth ofmammary tumours (Miller et al., 1981; Price et
al., 1990), and also for the expression of metastatic ability,
there being a higher frequency of metastasis from the mfp
tumours. Matrigel and mfp inoculation acted synergistically
to facilitate all cell lines to produce larger tumours but did
not induce the non-metastatic clones C3 and C4 to become
metastatic, although the prevalence of metastasis by the
parent line and by metastatic clones Cl and C2 was in-
creased. Such findings indicate that pulmonary metastasis
after inoculation, either s.c. or mfp, or with Matrigel,
primarily depends on intrinsic properties of the tumour cells
(Fidler, 1978; Tarin & Prince, 1979), but can be modulated
by local microenvironmental factors.
Recent results (Steeg et al., 1988; Hayle et al., 1993)
indicate that metastatic events occur as a result of genetic
disturbances which allow the inappropriate expression of
genes that are silent in most cells, enabling the cells affected
and their progeny to disseminate from the primary site. This
new evidence suggests that metastasis may occur as a conse-
quence either of failure ofa negative regulatory event respon-
sible for inhibiting inappropriate cell migration and distant
colonisation, perhaps involving the nm23 gene (Steeg et al.,
1988), or of the activation and up-regulation of a gene
capable of dominantly conferring the phenotype (Hayle et
al., 1993). In any event, once this balance has been disturbed,
it appears that microenvironmental influences, such as the
site of growth of the tumour cells or the constitution of the
adjacent tissue matrix, can accelerate tumour growth and
dissemination. The mechanisms by which this effect is medi-
ated deserve further investigation, to ascertain whether they
might be susceptible to pharmacological hindrance, which
could have the dual clinical benefit of retarding the growth of
secondary tumours as well as impeding further dissemina-
tion.
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